Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors

被引:158
作者
Valés-Gómez, M [1 ]
Reyburn, HT [1 ]
Erskine, RA [1 ]
Strominger, J [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
关键词
D O I
10.1073/pnas.95.24.14326
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Natural killer (NK) cell cytotoxicity is regulated in large part by the expression of NK cell receptors able to bind class I major histocompatibility complex glycoproteins. The receptors associated with recognition of HLA-C allospecificities are the two-domain Ig-like molecules, p50 and p58 proteins, with highly homologous extracellular domains but differing in that they have either an activating or inhibitory function, respectively, depending on the transmembrane domain and cytoplasmic tails that they possess. We have compared the binding to HLA-Cw7 of an inhibitory p58 molecule, NKAT2, the highly homologous activating p50 molecule, clone 49, and a second activating p50 molecule, clone 39, which has homologies to both NKAT1 and NKAT2. NKAT2 binds to HLA-Cw7 with very rapid association and dissociation rates. However, the p50 receptors bind only very weakly, if at all, to HLA-C. The molecular basis of this difference is analyzed, and the functional significance of these observations is discussed.
引用
收藏
页码:14326 / 14331
页数:6
相关论文
共 52 条
[1]   The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J].
Biassoni, R ;
Cantoni, C ;
Falco, M ;
Verdiani, S ;
Bottino, C ;
Vitale, M ;
Conte, R ;
Poggi, A ;
Moretta, A ;
Moretta, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :645-650
[2]  
BIASSONIR, 1997, EUR J IMMUNOL, V27, P3095
[3]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[4]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[5]   NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor [J].
Brooks, AG ;
Posch, PE ;
Scorzelli, CJ ;
Borrego, F ;
Coligan, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :795-800
[6]   The natural killer-related receptor for HLA-C expressed on T cells from CD3(+) lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function [J].
Cambiaggi, A ;
Orengo, AM ;
Meazza, R ;
Sforzini, S ;
Tazzari, PL ;
Lauria, F ;
Raspadori, D ;
Zambello, R ;
Semenzato, G ;
Moretta, L ;
Ferrini, S .
BLOOD, 1996, 87 (06) :2369-2375
[7]  
CAMBIER JC, 1995, J IMMUNOL, V155, P3281
[8]  
Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.0.CO
[9]  
2-F
[10]   The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules [J].
Carretero, M ;
Cantoni, C ;
Bellon, T ;
Bottino, C ;
Biassoni, R ;
Rodriguez, A ;
PerezVillar, JJ ;
Moretta, L ;
Moretta, A ;
LopezBotet, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :563-567